Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84,733,230
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
50,375,230
-
Shares change
-
+4,152,748
-
Total reported value, excl. options
-
$279,579,634
-
Value change
-
+$24,387,951
-
Number of buys
-
58
-
Number of sells
-
42
-
Price
-
$5.55
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q3 2022
As of 30 Sep 2022 SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) had 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 50,375,230 shares of stock of the company.
Largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., FRANKLIN RESOURCES INC, BVF INC/IL, Holocene Advisors, LP, EVENTIDE ASSET MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, and Candriam S.C.A..
This table shows 130 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.